|
Acadia Pharmaceuticals
|
14.58 |
|
0.47 |
3.33% |
-14.94% |
2025-04-11 |
|
Agios Pharmaceuticals
|
26.70 |
|
1.39 |
5.49% |
-9.52% |
2025-04-11 |
|
Alnylam Pharmaceuticals
|
237.77 |
|
11.49 |
5.08% |
60.11% |
2025-04-11 |
|
Amgen
|
285.87 |
|
4.62 |
1.64% |
7.05% |
2025-04-11 |
|
Biogen
|
115.15 |
|
1.69 |
1.49% |
-43.44% |
2025-04-11 |
|
BioMarin Pharmaceutical
|
56.82 |
|
0.50 |
0.89% |
-38.39% |
2025-04-11 |
|
Bristol-Myers Squibb
|
50.67 |
|
0.22 |
0.44% |
4.89% |
2025-04-11 |
|
Exelixis
|
35.31 |
|
0.85 |
2.47% |
54.80% |
2025-04-11 |
|
Gilead Sciences
|
103.58 |
|
2.30 |
2.27% |
52.19% |
2025-04-11 |
|
Incyte
|
56.87 |
|
1.70 |
3.08% |
5.61% |
2025-04-11 |
|
Ionis Pharmaceuticals
|
27.90 |
|
1.19 |
4.46% |
-33.16% |
2025-04-11 |
|
Eli Lilly
|
731.83 |
|
11.89 |
1.65% |
-2.50% |
2025-04-11 |
|
MacroGenics
|
1.29 |
|
0.04 |
3.20% |
-92.65% |
2025-04-11 |
|
Merck
|
79.14 |
|
1.68 |
2.17% |
-37.01% |
2025-04-11 |
|
Moderna
|
26.20 |
|
1.72 |
7.03% |
-75.53% |
2025-04-11 |
|
Neurocrine Biosciences
|
90.87 |
|
0.15 |
0.17% |
-32.52% |
2025-04-11 |
|
Novartis
|
87.70 |
|
1.61 |
1.87% |
1.39% |
2025-04-14 |
|
Novartis
|
107.54 |
|
3.71 |
3.57% |
14.89% |
2025-04-11 |
|
Pfizer
|
21.89 |
|
0.33 |
1.53% |
-15.42% |
2025-04-11 |
|
PTC Therapeutics
|
42.98 |
|
2.69 |
6.68% |
62.68% |
2025-04-11 |
|
Ultragenyx Pharmaceutical
|
34.14 |
|
0.98 |
2.96% |
-27.36% |
2025-04-11 |
|
Regeneron Pharmaceuticals
|
553.76 |
|
7.44 |
1.36% |
-38.75% |
2025-04-11 |
|
Sarepta Therapeutics
|
51.03 |
|
0.72 |
1.43% |
-58.47% |
2025-04-11 |
|
Vertex Pharmaceuticals
|
484.02 |
|
8.30 |
1.74% |
22.10% |
2025-04-11 |